UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1976
Dave & Buster's
PLAY
$247M
| $1.08M | ﹤0.01% |
59,331
-40,790
| -41% | -$1.07M |
2015 Q2
41 quarters
|
|
1977
USA Today Co
TDAY
$1.01B
| $1.07M | ﹤0.01% |
259,774
-144,913
| -36% | -$582K |
2024 Q3
4 quarters
|
|
1978
Compass Diversified
CODI
$811M
| $1.07M | ﹤0.01% |
161,601
-55,164
| -25% | -$380K |
2022 Q2
13 quarters
|
|
1979
VICI Properties
VICI
$25.4B
| $1.07M | ﹤0.01% |
32,714
-11,735,180
| -100% | -$387M |
2018 Q1
30 quarters
|
|
1980
Alpha and Omega Semiconductor
AOSL
$806M
| $1.07M | ﹤0.01% |
38,128
-26,121
| -41% | -$725K |
2021 Q4
15 quarters
|
|
1981
Arvinas
ARVN
$487M
| $1.07M | ﹤0.01% |
125,112
-57,499
| -31% | -$436K |
2019 Q4
23 quarters
|
|
1982
Trevi Therapeutics
TRVI
$1.84B
| $1.07M | ﹤0.01% |
+116,477
| New | +$873K |
2025 Q3
0 quarters
|
|
1983
OneSpan
OSPN
$658M
| $1.06M | ﹤0.01% |
66,958
-38,745
| -37% | -$589K |
2019 Q1
26 quarters
|
|
1984
Enliven Therapeutics
ELVN
$2.99B
| $1.06M | ﹤0.01% |
51,683
-31,371
| -38% | -$632K |
2024 Q2
5 quarters
|
|
|
PLYM
1985
DELISTED
Plymouth Industrial REIT
PLYM
| $1.06M | ﹤0.01% |
47,376
-59,108
| -56% | -$1.09M |
2021 Q4
15 quarters
|
|
1986
Relay Therapeutics
RLAY
$3.94B
| $1.06M | ﹤0.01% |
202,244
-206,658
| -51% | -$788K |
2020 Q3
20 quarters
|
|
1987
Mercantile Bank Corp
MBWM
$1.01B
| $1.05M | ﹤0.01% |
23,340
-18,630
| -44% | -$885K |
2023 Q1
10 quarters
|
|
1988
Kforce
KFRC
$906M
| $1.05M | ﹤0.01% |
35,028
-15,478
| -31% | -$548K |
2019 Q1
26 quarters
|
|
1989
Iovance Biotherapeutics
IOVA
$6.6B
| $1.05M | ﹤0.01% |
481,781
-175,428
| -27% | -$414K |
2015 Q4
39 quarters
|
|
1990
Opko Health
OPK
$1.03B
| $1.04M | ﹤0.01% |
673,565
-453,911
| -40% | -$623K |
2013 Q2
49 quarters
|
|
1991
ImmunityBio
IBRX
$10.7B
| $1.04M | ﹤0.01% |
422,831
-358,969
| -46% | -$924K |
2020 Q4
19 quarters
|
|
1992
Bloomin' Brands
BLMN
$751M
| $1.04M | ﹤0.01% |
144,763
-103,338
| -42% | -$831K |
2013 Q2
49 quarters
|
|
1993
Waste Connections
WCN
$38.7B
| $1.03M | ﹤0.01% |
5,880
-1,517,064
| -100% | -$276M |
2024 Q2
5 quarters
|
|
1994
Caleres
CAL
$421M
| $1.03M | ﹤0.01% |
79,121
-178,330
| -69% | -$2.58M |
2021 Q1
18 quarters
|
|
1995
JetBlue
JBLU
$1.37B
| $1.03M | ﹤0.01% |
208,927
-108,148
| -34% | -$520K |
2015 Q2
41 quarters
|
|
1996
Burke & Herbert Financial Services Corp
BHRB
$1.41B
| $1.03M | ﹤0.01% |
16,632
-20,291
| -55% | -$1.26M |
2024 Q3
4 quarters
|
|
1997
Itaú Unibanco
ITUB
$111B
| $1.03M | ﹤0.01% |
143,973
-52,226
| -27% | -$345K |
2025 Q2
1 quarter
|
|
1998
Beazer Homes USA
BZH
$892M
| $1.03M | ﹤0.01% |
41,776
-33,670
| -45% | -$827K |
2023 Q4
7 quarters
|
|
1999
National Presto Industries
NPK
$1.06B
| $1.02M | ﹤0.01% |
9,123
-11,655
| -56% | -$1.24M |
2024 Q1
6 quarters
|
|
2000
F&G Annuities & Life
FG
$2.47B
| $1.02M | ﹤0.01% |
32,702
-30,562
| -48% | -$1.01M |
2022 Q4
11 quarters
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.